MOLDTKPAC Q1 FY27 Results & Earnings Analysis
Sentiment: Good (Confidence: high)
Earnings Summary
Mold-Tek Packaging reported a strong Q1 FY27 with revenue crossing INR300 crores, driven by 25% top-line growth and a significant EBITDA per kg improvement to INR46.7. Growth was propelled by pharma (38% volume) and food/FMCG (24%) segments, while lube declined 17% due to geopolitical disruptions. Margin expansion came from unit consolidation, better product mix, and price pass-through. Management maintains a positive outlook, targeting 10% volume growth and EBITDA per kg of INR44-45 for FY27, with long-term focus on medical devices and pharma. Key risks include raw material volatility, war-related supply issues, and elevated working capital needs.
Management Tone
- Prepared Remarks: Good — Prepared remarks highlighted a landmark quarter with strong financial performance, effective price pass-through, and strategic consolidation benefits. The tone was positive and forward-looking.
- Q&A Session: Good — Analysts probed on volume growth, EBITDA sustainability, and segment performance. Management provided detailed, confident responses about long-term efficiency gains and growth drivers in pharma and food, addressing concerns about lube and Qpack.
Revenue Growth Drivers
- Strong growth in pharma (38% volume growth) and food/FMCG (24% volume growth) due to new customer additions and product demand.
- Price pass-through of increased raw material costs (from INR107 to INR130 per kg) to clients, sustaining revenue growth.
- Lube segment volume decline of 17% due to base oil unavailability from Middle East disruptions.
Growth vs Margin Focus
Management is driving volume growth (10% target) while improving EBITDA per kg through consolidation, automation, and product mix shift to high-margin pharma/food. They emphasize sustainable margin improvement.
About Mold-Tek Packaging Limited
Mold-Tek Packaging Limited (MOLDTKPAC) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.